Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xencor

10.60
+0.90009.28%
Pre-market: 10.01-0.5900-5.57%04:25 EDT
Volume:1.02M
Turnover:10.91M
Market Cap:746.90M
PE:-2.96
High:10.98
Open:9.65
Low:9.46
Close:9.70
Loading ...

Xencor Initiated at Outperform by William Blair

Dow Jones
·
Yesterday

William Blair Initiates Xencor at Outperform

MT Newswires Live
·
Yesterday

Xencor initiated with an Outperform at William Blair

TIPRANKS
·
Yesterday

US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says

MT Newswires Live
·
11 Apr

Xencor Appoints Todd Simpson To Board Of Directors

Reuters
·
14 Mar

Xencor Appoints Todd Simpson to Board of Directors

Business Wire
·
14 Mar

BEAM Down Despite Positive Initial Data From Genetic Disorder Study

Zacks
·
12 Mar

PSTV Stock Skyrockets on FDA's Orphan Drug Tag for Cancer Therapy

Zacks
·
07 Mar

Barclays Reaffirms Their Sell Rating on Xencor (XNCR)

TIPRANKS
·
02 Mar

Xencor Is Maintained at Overweight by Wells Fargo

Dow Jones
·
01 Mar

RBC Capital Adjusts Xencor Price Target to $32 From $34, Maintains Outperform - Speculative Risk Rating

MT Newswires Live
·
28 Feb

Xencor price target lowered to $31 from $38 at Wedbush

TIPRANKS
·
28 Feb

Wedbush Cuts Price Target on Xencor to $31 From $38, Keeps Outperform Rating

MT Newswires Live
·
28 Feb

Xencor Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
28 Feb

Strategic Shift and Promising Pipeline: Xencor’s Growth Potential and Investment Opportunity

TIPRANKS
·
28 Feb

Xencor Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Xencor's Q4 Net Loss Widens, Revenue Rises

MT Newswires Live
·
27 Feb

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
27 Feb

Xencor reports Q4 EPS ( 62c), consensus (78c)

TIPRANKS
·
27 Feb

Xencor: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb